MELVILLE, N.Y.--(BUSINESS WIRE)--OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) announced today that it will host a live webcast of its R&D Analyst Day on Thursday, December 3, 2009 at 12:30 p.m. Eastern Time. The webcast will be hosted by Colin Goddard, Ph.D., Chief Executive Officer, and members of OSI’s management team. The Company will discuss the status of its oncology and diabetes/obesity research and development programs, including its Tarceva® (erlotinib) program, and will also provide a brief financial overview. The webcast is expected to last approximately three hours.
